-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $42

Benzinga·05/06/2026 14:05:25
Listen to the news
Wells Fargo analyst Colin Langan maintains Versigent (NYSE:VGNT) with a Overweight and raises the price target from $35 to $42.